Refractory ascites in cirrhosis: Mechanism and treatment

V. Arroyo, M. Epstein, G. Gallus, P. Gentilini, H. Ring-Larsen, F. Salerno

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Refractory ascites (or diuretic-resistant ascites), i.e. the ascites that cannot be mobilised by medical treatment (low sodium diet and high doses of furosemide and spironolactone), is an infrequent phenomenon in cirrhosis. It usually occurs in patients with functional renal failure as a consequence of alterations in both pharmacokinetics and pharmacodynamics of diuretics. Peritoneo-venous shunting, a procedure which improves systemic haemodynamics and renal function in cirrhotics with ascites, has been proposed as the treatment of choice in patients with refractory ascites. Unfortunately, it is associated with a high rate of severe complications and does not prolong the survival of these patients. Recent studies have shown that large-volume paracentesis plus i.v. albumin infusion is an effective and safe therapy of ascites in cirrhosis and that it could be an alternative treatment for refractoy ascites. Controlled trials are needed to determine which of these two therapeutic procedures is better for the management of diuretic-resistant ascites in cirrhosis.

Original languageEnglish
Pages (from-to)195-207
Number of pages13
JournalGastroenterology International
Volume2
Issue number4
Publication statusPublished - 1989

Fingerprint

Ascites
Fibrosis
Diuretics
Therapeutics
Paracentesis
Sodium-Restricted Diet
Spironolactone
Furosemide
Renal Insufficiency
Albumins
Pharmacokinetics
Hemodynamics
Kidney
Survival

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Arroyo, V., Epstein, M., Gallus, G., Gentilini, P., Ring-Larsen, H., & Salerno, F. (1989). Refractory ascites in cirrhosis: Mechanism and treatment. Gastroenterology International, 2(4), 195-207.

Refractory ascites in cirrhosis : Mechanism and treatment. / Arroyo, V.; Epstein, M.; Gallus, G.; Gentilini, P.; Ring-Larsen, H.; Salerno, F.

In: Gastroenterology International, Vol. 2, No. 4, 1989, p. 195-207.

Research output: Contribution to journalArticle

Arroyo, V, Epstein, M, Gallus, G, Gentilini, P, Ring-Larsen, H & Salerno, F 1989, 'Refractory ascites in cirrhosis: Mechanism and treatment', Gastroenterology International, vol. 2, no. 4, pp. 195-207.
Arroyo V, Epstein M, Gallus G, Gentilini P, Ring-Larsen H, Salerno F. Refractory ascites in cirrhosis: Mechanism and treatment. Gastroenterology International. 1989;2(4):195-207.
Arroyo, V. ; Epstein, M. ; Gallus, G. ; Gentilini, P. ; Ring-Larsen, H. ; Salerno, F. / Refractory ascites in cirrhosis : Mechanism and treatment. In: Gastroenterology International. 1989 ; Vol. 2, No. 4. pp. 195-207.
@article{279a0975571c46b4bb8445a62f9b40fa,
title = "Refractory ascites in cirrhosis: Mechanism and treatment",
abstract = "Refractory ascites (or diuretic-resistant ascites), i.e. the ascites that cannot be mobilised by medical treatment (low sodium diet and high doses of furosemide and spironolactone), is an infrequent phenomenon in cirrhosis. It usually occurs in patients with functional renal failure as a consequence of alterations in both pharmacokinetics and pharmacodynamics of diuretics. Peritoneo-venous shunting, a procedure which improves systemic haemodynamics and renal function in cirrhotics with ascites, has been proposed as the treatment of choice in patients with refractory ascites. Unfortunately, it is associated with a high rate of severe complications and does not prolong the survival of these patients. Recent studies have shown that large-volume paracentesis plus i.v. albumin infusion is an effective and safe therapy of ascites in cirrhosis and that it could be an alternative treatment for refractoy ascites. Controlled trials are needed to determine which of these two therapeutic procedures is better for the management of diuretic-resistant ascites in cirrhosis.",
author = "V. Arroyo and M. Epstein and G. Gallus and P. Gentilini and H. Ring-Larsen and F. Salerno",
year = "1989",
language = "English",
volume = "2",
pages = "195--207",
journal = "Gastroenterology International",
issn = "0950-5911",
publisher = "International Universities Press Inc.",
number = "4",

}

TY - JOUR

T1 - Refractory ascites in cirrhosis

T2 - Mechanism and treatment

AU - Arroyo, V.

AU - Epstein, M.

AU - Gallus, G.

AU - Gentilini, P.

AU - Ring-Larsen, H.

AU - Salerno, F.

PY - 1989

Y1 - 1989

N2 - Refractory ascites (or diuretic-resistant ascites), i.e. the ascites that cannot be mobilised by medical treatment (low sodium diet and high doses of furosemide and spironolactone), is an infrequent phenomenon in cirrhosis. It usually occurs in patients with functional renal failure as a consequence of alterations in both pharmacokinetics and pharmacodynamics of diuretics. Peritoneo-venous shunting, a procedure which improves systemic haemodynamics and renal function in cirrhotics with ascites, has been proposed as the treatment of choice in patients with refractory ascites. Unfortunately, it is associated with a high rate of severe complications and does not prolong the survival of these patients. Recent studies have shown that large-volume paracentesis plus i.v. albumin infusion is an effective and safe therapy of ascites in cirrhosis and that it could be an alternative treatment for refractoy ascites. Controlled trials are needed to determine which of these two therapeutic procedures is better for the management of diuretic-resistant ascites in cirrhosis.

AB - Refractory ascites (or diuretic-resistant ascites), i.e. the ascites that cannot be mobilised by medical treatment (low sodium diet and high doses of furosemide and spironolactone), is an infrequent phenomenon in cirrhosis. It usually occurs in patients with functional renal failure as a consequence of alterations in both pharmacokinetics and pharmacodynamics of diuretics. Peritoneo-venous shunting, a procedure which improves systemic haemodynamics and renal function in cirrhotics with ascites, has been proposed as the treatment of choice in patients with refractory ascites. Unfortunately, it is associated with a high rate of severe complications and does not prolong the survival of these patients. Recent studies have shown that large-volume paracentesis plus i.v. albumin infusion is an effective and safe therapy of ascites in cirrhosis and that it could be an alternative treatment for refractoy ascites. Controlled trials are needed to determine which of these two therapeutic procedures is better for the management of diuretic-resistant ascites in cirrhosis.

UR - http://www.scopus.com/inward/record.url?scp=0024787680&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024787680&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0024787680

VL - 2

SP - 195

EP - 207

JO - Gastroenterology International

JF - Gastroenterology International

SN - 0950-5911

IS - 4

ER -